Degarelix Acetate

Cat#: CFGP-016 

CAS-Number：214766-78-6

Molecular Formula：C82H103ClN18O16

Molecular Weight: 1632.28

Sequence：Ac-D-2-Nal-D-4-Cpa-D-3-Pal-Ser-4-amino-Phe(L-hydroorotyl)-4-ureido-D-Phe-Leu-Lys(isopropyl)-Pro-D-Ala-NH2 acetate salt

Fields of Application：Advanced hormone-dependent prostate carcinoma

Active Substance：Degarelix Acetate is an LHRH (GnRH) receptor antagonist, indicated for patients with advanced prostate cancer. Degarelix reversibly and dose-dependently suppresses gonadotropin and sex steroid levels by inhibiting the binding of endogenous LHRH to its receptors.Degarelix showed to be at least as effective as leuprolide in sustaining levels of testosterone that are equivalent to or lower than that seen with castration.
This product is offered and sold solely for uses reasonably related to the development and submission of information under a Federal law which regulates the manufacture, use or sale of drugs (the “Bolar Exemption”). Bachem cannot be made liable for any infringement of intellectual property rights. It is the sole and only responsibility of the purchaser or user of this product to comply with the relevant national rules and regulations

 

Order